HomeCompareADNRX vs ORCC

ADNRX vs ORCC: Dividend Comparison 2026

ADNRX yields 10.70% · ORCC yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADNRX wins by $12.5K in total portfolio value
10 years
ADNRX
ADNRX
● Live price
10.70%
Share price
$18.70
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.6K
Annual income
$2,091.04
Full ADNRX calculator →
ORCC
ORCC
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full ORCC calculator →

Portfolio growth — ADNRX vs ORCC

📍 ADNRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADNRXORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADNRX + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADNRX pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADNRX
Annual income on $10K today (after 15% tax)
$909.09/yr
After 10yr DRIP, annual income (after tax)
$1,777.38/yr
ORCC
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, ADNRX beats the other by $1,013.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADNRX + ORCC for your $10,000?

ADNRX: 50%ORCC: 50%
100% ORCC50/50100% ADNRX
Portfolio after 10yr
$34.3K
Annual income
$1,495.12/yr
Blended yield
4.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

ADNRX
No analyst data
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
-68.0% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADNRX buys
0
ORCC buys
0
No recent congressional trades found for ADNRX or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADNRXORCC
Forward yield10.70%4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5%
5-year div CAGR0%5%
Portfolio after 10y$40.6K$28.0K
Annual income after 10y$2,091.04$899.19
Total dividends collected$15.7K$6.4K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: ADNRX vs ORCC ($10,000, DRIP)

YearADNRX PortfolioADNRX Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$11,770$1,069.52$11,120$420.00+$650.00ADNRX
2$13,770$1,176.42$12,357$458.31+$1.4KADNRX
3$16,020$1,286.32$13,721$499.76+$2.3KADNRX
4$18,540$1,398.62$15,227$544.58+$3.3KADNRX
5$21,351$1,512.74$16,885$593.02+$4.5KADNRX
6$24,473$1,628.09$18,713$645.34+$5.8KADNRX
7$27,930$1,744.12$20,724$701.81+$7.2KADNRX
8$31,746$1,860.29$22,938$762.73+$8.8KADNRX
9$35,944$1,976.08$25,372$828.41+$10.6KADNRX
10$40,551$2,091.04$28,047$899.19+$12.5KADNRX

ADNRX vs ORCC: Complete Analysis 2026

ADNRXStock

Under normal circumstances, substantially all of the fund's assets are invested in a portfolio of equity securities including common stocks and other equity investments or ownership interests in business enterprises that are relevant to the fund's investment theme of transformational innovation. The fund's investments in foreign equity securities are principally in developed markets. It invests in American Depositary Receipts (''ADRs'') and securities sold on foreign exchanges and securities denominated in foreign currencies when purchasing foreign equities. The fund is non-diversified.

Full ADNRX Calculator →

ORCCBDC

ORCC is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in ORCC shares.

Full ORCC Calculator →
📬

Get this ADNRX vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADNRX vs SCHDADNRX vs JEPIADNRX vs OADNRX vs KOADNRX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.